etoposide has been researched along with Cancer of Cervix in 114 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (7.89) | 18.7374 |
1990's | 35 (30.70) | 18.2507 |
2000's | 30 (26.32) | 29.6817 |
2010's | 34 (29.82) | 24.3611 |
2020's | 6 (5.26) | 2.80 |
Authors | Studies |
---|---|
Jeong, YT; Kim, SK; Pallela, R; Park, DH; Parthiban, P | 1 |
Kruakaew, S; Lhinhatrakool, T; Piyaviriyakul, S; Seeka, C; Siripong, P; Sutthivaiyakit, S; Thongnest, S; Yahuafai, J | 1 |
Lai, CH; Liu, FY; Tung, HJ; Wang, CC | 1 |
An, J; Huang, M; Huang, Y; Li, C; Li, L; Luo, S; Peng, Y; Wang, J; Wang, Z; Wu, L; Yang, H; Yang, X; Zhang, Y | 1 |
Chopra, M; Kaur, S; Rajoria, P | 1 |
Kimura, T; Kurita, T; Miyoshi, AI; Ueda, Y; Yoshino, K | 1 |
Bhosale, P; Chisholm, GB; Flores Legarreta, A; Frumovitz, M; Gonzales, NR; Jhingran, A; Ramalingam, P; Saab, R; Salvo, G | 1 |
Chargari, C; Escande, A; Espenel, S; Morcet-Delattre, R; Tas, P | 1 |
Chang, KM; Chang, SJ; Chen, TC; Chen, YT; Chuang, YJ; Lai, ZY; Yeo, HY | 1 |
Cheng, YM; Chiang, CT; Chou, CY; Huang, YF; New, GH; Tsai, HW; Wu, PY | 1 |
Cheng, Y; He, T; Pei, X; Wu, X; Xiang, L; Yang, H; Yang, W; Ye, S | 1 |
Choi, KH; Hur, SY; Kim, JY; Kim, YS; Lee, DS; Lee, SW; Lee, YH; Park, HH; Park, JS; Sung, S; Yoon, SC | 1 |
Ben Mrad, M; Chauleur, C; de Laroche, G; Espenel, S; Garcia, MA; Guy, JB; Langrand-Escure, J; Magné, N; Moreno-Acosta, P; Rancoule, C; Trone, JC; Vallard, A | 1 |
Hwang, J; Kim, DW; Lee, EJ | 1 |
Bjerke, GA; Muhlrad, D; Parker, R; Shukla, S; Yi, R | 1 |
Anderson, RA; Li, W | 1 |
Lee, DW; Lee, HN; Lee, JW; Lee, KH; Park, JS; Park, ST | 1 |
Cheng, XL; Huang, L; Liao, LM; Lin, JX; Liu, AW; Wu, JB; Zheng, M | 1 |
Bellefqih, S; Benjaafar, N; Kebdani, T; Khalil, J; Mezouri, I | 1 |
Kadalayil, L; KhoshZaban, M; Kuku, S; Ledermann, J; Loddo, M; McCormack, M; Proctor, I | 1 |
Du, XL; Li, HQ; Lu, CH; Pan, CX; Sheng, XG; Wang, C; Yin, YJ | 1 |
Bae, J; Jin, H; Kim, TH; Lee, K; Suh, DS; Yeom, JH | 1 |
Fang, J; Liu, LF; Wu, MJ; Yin, ZM; Yu, AJ; Yu, H; Zhu, JQ | 1 |
Armato, U; Chiarini, A; Dal Prà, I; Liu, D | 1 |
Bhattacharya, S; Maiti, A | 1 |
Bohle, RM; Büttner, R; Fischbach, J; Horn, LC; Juhasz-Böss, I; Kim, YJ; Mallmann, P; Pahne-Zeppenfeld, J; Rübe, C; Smola, S; Solomayer, EF; Stern, P; Ströder, R; Tharun, L; Walch-Rückheim, B; Wickenhauser, C | 1 |
Algren, SD; Dziadek, OL; Ruiz, MP | 1 |
Bae, JH; Bae, SN; Lee, A; Lee, SJ; Namkoong, SE; Park, JS; Park, YG | 1 |
Nagai, T; Okubo, T; Sakaguchi, R; Seki, H; Takeda, S | 1 |
Abu-Rustum, NR; Aghajanian, C; Alektiar, K; Chi, DS; Diaz, JP; Konner, J; Leitao, MM; Park, KJ; Zhao, H; Zivanovic, O | 1 |
Chan, MY; Leung, CW; Li, WW; Pong, WM; Yau, TN | 1 |
Bhattacharya, RK; Dey, S; Mukherjee, S; Roy, M | 1 |
Gouliamos, A; Koukourakis, GV; Kouloulias, V; Maravelis, G; Papadimitriou, C; Platoni, K; Zacharias, G | 1 |
Guo, LN; Han, XY; Huang, HF; Pan, LY; Sheng, K; Wan, XR; Xiang, Y | 1 |
Chan, JK; Chen, LM; Cohen, JG; Kapp, DS; Osann, K; Sherman, AE; Shin, JY; Urban, R | 1 |
Donaldson, MM; Dornan, ES; Fisk, JC; King, LE; Melendy, T; Morgan, IM | 1 |
Bae, SN; Chun, SH; Hong, SH; Hur, SY; Jeon, EK; Lee, A; Lee, KH; Park, JS; Won, HS; Yoon, SC | 1 |
Lee, DW; Lee, HN; Lee, KH; Lee, YS; Park, EK; Park, JS | 1 |
Futagami, M; Mizunuma, H; Yokoyama, Y | 1 |
Hatae, M; Hoshiai, H; Isaka, K; Kamiura, S; Kawamura, N; Nakanishi, T; Ochiai, K; Ohmichi, M; Tanaka, N; Watanabe, Y | 1 |
Bouvy, JJ; Braun, JJ; Ruit, JB | 1 |
Guo, N; Lou, J; Peng, Z; Yang, K | 1 |
Hai-Yan, S; Jian-Qing, Z; Lan-Fang, L; Ya-Qing, C; Zuo-Ming, Y | 1 |
Armato, U; Chiarini, A; Dal Prà, I; Marconi, M; Pacchiana, R; Wu, J | 1 |
Bian, ML; Higuma, C; Isaka, K; Ito, H; Liang, J; Nishi, H; Sasaki, T | 1 |
Ito, K; Kaiho-Sakuma, M; Kurosawa, H; Nagai, T; Nagase, S; Niikura, H; Otsuki, T; Takano, T; Tanaka, S; Tokunaga, H; Toyoshima, M; Utsunomiya, H; Yaegashi, N; Yoshinaga, K | 1 |
Blessing, JA; Buller, RE; Mannel, RS; Rose, PG; Webster, KD | 1 |
Aquino-Parsons, C; Hoskins, PJ; Lee, N; Lim, P; Pike, JA; Swenerton, KD; Wong, F | 1 |
Fiorica, JV | 1 |
HELD, F; SCHWARZ, R | 1 |
Hoshino, H; Saitoh, K; Seki, H; Sodemoto, T; Takada, T; Uekusa, T | 1 |
Ivanov, S; Zervoudis, S | 1 |
Nishiura, K; Obata, H; Okugawa, T; Tabata, T; Tanaka, K; Toyoda, N; Yanoh, K | 1 |
Linghu, H; Mei, YY; Sun, T; Tang, JY; Tang, LD; Xu, XR | 1 |
Banáth, JP; Olive, PL; Sinnott, LT | 1 |
Hara, K; Iwasaka, T | 1 |
Al, A; Baykal, C; Bulbul, D; Güler, G; Küçükali, T; Ozer, S; Tulunay, G | 1 |
Scorilas, A; Thomadaki, H; Tsiapalis, CM | 1 |
Burger, CW; Ewing, P; Seynaeve, C; Snijders-Keilholz, A | 1 |
Bai, T; Tanaka, T; Umesaki, N; Yukawa, K | 1 |
Kroemer, G; Larochette, N; Massard, C; Métivier, D; Pauleau, AL; Sabatier, L; Soria, JC; Zermati, Y | 1 |
Feng, YL; Li, JD; Li, MD; Liu, JH; Shi, HL; Xiao, Y | 1 |
Kim, JJ; Lee, SB; Park, JS; Tong, SY; Um, SJ | 1 |
Blessing, JA; Homesley, HD; Slayton, RE | 1 |
Charrot-Chinet, P; Chauvergne, J; Héron, JF; Mayer, F; Toulouse, C | 1 |
Ho, ES; Hsu, WP; Jan, JS; Lin, JC; Yang, CH | 1 |
Banáth, JP; Fjell, CD; Olive, PL | 1 |
Hayakawa, O; Kudo, R; Takehara, M | 1 |
Hoshino, K; Mitsuya, T; Morioka, M; Noguchi, Y; Notake, Y; Okuyama, D; Shimizu, A; Takahashi, J; Watanabe, S; Yoda, A | 1 |
Baillet, F; Delanian, S; Housset, M; Lecuru, F; Maulard-Durdux, C; Taurelle, R | 1 |
Hara, K; Iwasaka, T; Matsuo, N; Mvula, M; Nakao, Y; Sugimori, H; Yamasaki, F; Yokoyama, M | 1 |
Neijt, JP | 1 |
Acker, B; Hoskins, PJ; Le Riche, J; Manji, M; McMurtrie, E; Pike, JA; Swenerton, KD; Wong, F | 1 |
Cimoli, G; Conte, P; Mariani, GL; Parodi, S; Russo, P; Valenti, M; Venturini, M | 1 |
Ho, ES; Jan, JS; Lin, JC; Liu, FS; Yang, CH | 1 |
Clynes, M; Dolan, E; Heenan, M; Kavanagh, K; Maher, M; Moriarty, M; O'Neill, P; Redmond, A | 1 |
Hayashi, N; Ikeba, K; Kinoshita, K; Ohokubo, T; Sodemoto, T; Takagi, A; Takeda, S; Yamamoto, T | 1 |
Al-Saleh, E; Hoskins, PJ; Pike, JA; Swenerton, KD | 1 |
Ikeba, K; Kimura, M; Kinoshita, K; Maeda, H; Ohkubo, T; Sodemoto, T; Suwata, J; Suzuki, Y; Takagi, A; Takeda, S; Yamamoto, T | 1 |
Bishop, JF; Millward, MJ; Quinn, M; Rischin, D; Rome, R; Tebbutt, N; Toner, GC | 1 |
Chang, L; Ogita, S; Tanaka, T; Umesaki, N | 1 |
Beppu, M; Chiba, T; Hiura, M; Kawakami, Y; Nogawa, T; Yokoyama, T | 1 |
Chang, TC; Chou, HH; Hsueh, S; Huang, KG; Lai, CH; Tseng, CJ | 1 |
Brader, KR; Burke, TW; Gershenson, DM; Levenback, CF; Morris, M | 1 |
Fukuda, K; Hara, K; Iwasaka, T; Nakao, Y; Sugimori, H; Uchiyama, M; Yokoyama, M | 1 |
Blessing, JA; Rose, PG; Van Le, L; Waggoner, S | 1 |
Fujii, S; Hasegawa, K; Hirabayasi, K; Ikeda, M; Izumi, R; Kono, I; Kudo, R; Niitani, H; Nishiya, I; Noda, K; Ochiai, K; Ogita, Y; Okada, H; Ozaki, M; Saito, T; Sugimori, H; Suzuoki, Y; Tanaka, K; Terashima, Y; Tomoda, Y; Umesaki, N; Yajima, A; Yakushiji, M; Yamabe, T; Yamamoto, T | 1 |
Hatae, M; Hiura, M; Hoshiai, H; Ikeda, M; Izumi, R; Noda, K; Ogita, Y; Okada, H; Ozaki, M; Ozawa, M; Tamaya, T; Tanaka, K; Yamabe, T | 1 |
Chao, HT; Chiang, H; Lai, CR; Lee, SD; Lee, WL; Ng, HT; Tseng, JY; Wang, PH; Yuan, CC | 1 |
Leung, TW; Lo, SH; O, SK; Sze, WK; Tung, SY; Wong, FC; Wong, SF; Yuen, MK | 1 |
Fushiki, H; Hasegawa, K; Izumi, R; Kono, I; Nishida, M; Noda, K; Noguchi, H; Okuda, H; Sugimori, H; Takizawa, K; Tanaka, T; Udagawa, Y; Umesaki, N; Yamamoto, K | 1 |
Fujita, T; Hayashi, T; Higashihara, J; Irie, T; Ohishi, Y; Shigematsu, T | 1 |
Banáth, JP; Johnston, PJ; MacPhail, SH; Olive, PL; Oloumi, A | 1 |
Angelelli, B; Bovicelli, A; Ceccarelli, C; Costa, S; Erzén, M; Lipponen, P; Martoni, A; Santini, D; Syrjänen, K; Syrjänen, S; Terzano, P | 1 |
Amo-Takyi, BK; Boabang, P; Kohlhagen, H; Kurbacher, CM; Waida, A | 1 |
Artusi, T; Bonacorsi, G; Longo, L; Rivasi, F; Rossi, G | 1 |
Boruta, DM; Castrillon, DH; Crum, CP; Duska, LA; Schorge, JO; Sheets, EE | 1 |
Khanna, N; Reddy, VG; Singh, N | 1 |
Dalrymple, C; Firth, I; MacLeod, C; O'Donnell, A; Tattersall, MH | 1 |
Alftan, H; Lehtovirta, P; Leminen, A; Stenman, UH | 1 |
Burke, TW; Eifel, P; Gershenson, DM; Mitchell, MF; Morris, M; Silva, EG; Wharton, JT | 1 |
Chang, TC; Hsu, JJ; Hsueh, S; Soong, YK | 1 |
Fushiki, H | 1 |
Ehrlich, L; Goldberg, GL; Jones, JG; O'Hanlan, KA; Rodriguez-Rodriguez, L; Runowicz, CD | 1 |
Kredentser, DC | 1 |
Ishii, S; Itoh, O; Kariya, Y; Kawaharajo, K; Nagasawa, M; Takeuchi, T; Yamamoto, H | 1 |
Eiermann, W; Fateh-Moghadam, A; Hepp, H; Meier, W; Schneider, A; Stieber, P | 1 |
Kelland, LR; Steel, GG; Tonkin, KS | 1 |
Kelland, LR; Tonkin, KS | 1 |
Coffman, FD; Godwin, A; Green, LM; Ware, CF | 1 |
Eiermann, W; Fateh-Moghadam, A; Hepp, H; Meier, W; Stieber, P | 1 |
Kawashima, Y; Kobayashi, H | 1 |
Kubo, H; Maeda, T; Okamura, S; Sano, T; Sugimoto, O; Ueda, M; Ueki, M; Yamada, T | 1 |
Grönroos, M; Kangas, L; Mäenpää, J | 1 |
11 review(s) available for etoposide and Cancer of Cervix
Article | Year |
---|---|
Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cervix Uteri; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Staging; Platinum; Rare Diseases; Small Cell Lung Carcinoma; Uterine Cervical Neoplasms | 2023 |
Role of radiotherapy in the management of rare gynaecological cancers.
Topics: Brachytherapy; Carcinoma, Neuroendocrine; Etoposide; Female; Humans; Retrospective Studies; Uterine Cervical Neoplasms | 2023 |
[Small cell neuroendocrine carcinoma of the uterine cervix: Report of six cases and a review of the literature].
Topics: Adult; Antineoplastic Agents; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasm Metastasis; Radiotherapy, Adjuvant; Retrospective Studies; Uterine Cervical Neoplasms | 2014 |
Embryonal rhabdomyosarcoma of the uterine cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Diagnostic Errors; Etoposide; Female; Humans; Hysterectomy; Ifosfamide; Lymph Node Excision; Ovariectomy; Particle Accelerators; Photons; Polyps; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Remission Induction; Rhabdomyosarcoma, Embryonal; Uterine Cervical Neoplasms; Uterine Hemorrhage; Young Adult | 2009 |
Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Kaplan-Meier Estimate; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Registries; Uterine Cervical Neoplasms | 2010 |
The role of topotecan in the treatment of advanced cervical cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Drug Synergism; Etoposide; Female; Humans; Paclitaxel; Topotecan; Uterine Cervical Neoplasms | 2003 |
[Chemotherapy with mitomycin C, etoposide and cisplatin for adenocarcinoma of the uterine cervix].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Mitomycin; Neoadjuvant Therapy; Prognosis; Uterine Cervical Neoplasms | 2004 |
Primitive neuroectodermal tumor of the cervix uteri: a case report -- changing concepts in therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Mesna; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive, Peripheral; Uterine Cervical Neoplasms; Vincristine | 2005 |
Advances in the chemotherapy of gynecologic cancer.
Topics: Altretamine; Antineoplastic Agents; Clinical Trials as Topic; Endometrial Neoplasms; Etoposide; Female; Genital Neoplasms, Female; Germinoma; Humans; Ovarian Neoplasms; Pregnancy; Trophoblastic Neoplasms; Uterine Cervical Neoplasms | 1994 |
Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Hysterectomy; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Uterine Cervical Neoplasms; Vincristine | 2001 |
Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix: review of the literature.
Topics: Adult; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Endocrine Gland Neoplasms; Etoposide; Female; Humans; Middle Aged; Nervous System Neoplasms; Uterine Cervical Neoplasms | 1991 |
20 trial(s) available for etoposide and Cancer of Cervix
Article | Year |
---|---|
Do Cell-Cycle Phase-Specific Markers Predict Disease Grade, Stage, and Outcome in Cervical Carcinoma?
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Squamous Cell; Cell Cycle; Chemoradiotherapy; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Prognosis; Survival Rate; Uterine Cervical Neoplasms; Young Adult | 2015 |
Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Uterine Cervical Neoplasms; Young Adult | 2008 |
ERCC1 (excision repair cross-complementation group 1) expression as a predictor for response of neoadjuvant chemotherapy for FIGO stage 2B uterine cervix cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; DNA Repair; DNA-Binding Proteins; Endonucleases; Etoposide; Female; Humans; Immunohistochemistry; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Predictive Value of Tests; Uterine Cervical Neoplasms | 2011 |
Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Hysterectomy; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Proportional Hazards Models; Radiotherapy, Adjuvant; Survival Rate; Uterine Cervical Neoplasms | 2011 |
Small cell carcinoma of the uterine cervix: clinical outcome of concurrent chemoradiotherapy with a multidrug regimen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Endpoint Determination; Etoposide; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Middle Aged; Neutropenia; Prednisone; Treatment Outcome; Uterine Cervical Neoplasms; Vincristine | 2013 |
Prolonged oral etoposide in recurrent or advanced non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Adenosquamous; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Uterine Cervical Neoplasms | 2003 |
[Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Mitomycins; Uterine Cervical Neoplasms | 1993 |
Concomitant chemoradiotherapy for advanced epidermoid carcinoma of the uterine cervix: a preliminary report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Prospective Studies; Remission Induction; Uterine Cervical Neoplasms | 1994 |
Small cell carcinoma of the cervix treated with concurrent radiotherapy, cisplatin, and etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Uterine Cervical Neoplasms | 1995 |
[Clinical effect of intra-arterial carboplatin-combined chemotherapy for advanced uterine cervical cancer and increased tissue platinum levels with Lipo PGE1 administration before chemotherapy].
Topics: Adenocarcinoma; Adult; Aged; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cervix Uteri; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Female; Humans; Iliac Artery; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Platinum; Uterine Cervical Neoplasms; Vindesine | 1996 |
Cisplatin/etoposide chemotherapy for recurrent or primarily advanced cervical carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Recurrence, Local; Quality of Life; Remission Induction; Survival Rate; Uterine Cervical Neoplasms | 1997 |
A phase II trial of carboplatin and etoposide for relapsed or metastatic carcinoma of the cervix.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Confidence Intervals; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 1998 |
Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Uterine Cervical Neoplasms; Vinblastine; Vincristine | 1998 |
A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1998 |
Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1998 |
[Early phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical or ovarian cancer. ETP 21 Study Group--Cervical-Ovarian Cancer Group].
Topics: Administration, Oral; Adult; Aged; Alopecia; Anorexia; Antineoplastic Agents, Phytogenic; Drug Administration Schedule; Etoposide; Female; Humans; Leukopenia; Middle Aged; Nausea; Neutropenia; Ovarian Neoplasms; Thrombocytopenia; Uterine Cervical Neoplasms | 1998 |
[Late phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical cancer. ETP 21 Study Group--Cervical Cancer Group].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Nausea; Uterine Cervical Neoplasms; Vomiting | 1998 |
Cervical adenocarcinoma, a novel combination chemotherapy with mitomycin C, etoposide, and cisplatin for advanced or recurrent disease.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Etoposide; Female; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Uterine Cervical Neoplasms | 1999 |
CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.
Topics: Adenocarcinoma; Adult; Aged; alpha Catenin; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Biomarkers, Tumor; Bleomycin; Cadherins; Carcinoma, Adenosquamous; Cisplatin; Cytoskeletal Proteins; Disease-Free Survival; Epirubicin; Etoposide; Female; Glycoproteins; Humans; Hyaluronan Receptors; Hysterectomy; Immunohistochemistry; Middle Aged; Neoadjuvant Therapy; Survival Rate; Trans-Activators; Uterine Cervical Neoplasms | 2001 |
Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Hysterectomy; Infusions, Intravenous; Middle Aged; Neoplasm Staging; Prospective Studies; Uterine Cervical Neoplasms | 1992 |
83 other study(ies) available for etoposide and Cancer of Cervix
Article | Year |
---|---|
Synthesis of polyfunctionalized piperidone oxime ethers and their cytotoxicity on HeLa cells.
Topics: Antineoplastic Agents; Cell Survival; Ethers; Female; HeLa Cells; Humans; Oximes; Piperidones; Structure-Activity Relationship; Uterine Cervical Neoplasms | 2011 |
Cytotoxic Cardiac Glycoside Constituents of Vallaris glabra Leaves.
Topics: Antineoplastic Agents, Phytogenic; Apocynaceae; Cardenolides; Cardiac Glycosides; Female; Glycosides; Humans; Inhibitory Concentration 50; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plant Leaves; Thailand; Uterine Cervical Neoplasms | 2017 |
Complete remission of advanced and recurrent cervical cancer with pembrolizumab treatment- 3 case reports.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2021 |
Therapeutic strategy analysis of patients with advanced stage high-grade neuroendocrine cervical cancer: A real-world multicenter study.
Topics: Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Neoplasm Staging; Paclitaxel; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2022 |
Ricolinostat suppresses proliferation, promotes apoptosis, and enhances the antiproliferative activity of topoisomerase inhibitors in cervical cancer cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Etoposide; Female; Humans; Reactive Oxygen Species; Topoisomerase Inhibitors; Topotecan; Uterine Cervical Neoplasms | 2022 |
Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study.
Topics: Adult; Aged; Aged, 80 and over; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Staging; Neuroendocrine Tumors; Prognosis; Registries; Retrospective Studies; Uterine Cervical Neoplasms; Young Adult | 2023 |
PI3K inhibitor enhances the cytotoxic response to etoposide and cisplatin in a newly established neuroendocrine cervical carcinoma cell line.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers; Carcinoma, Neuroendocrine; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Disease Models, Animal; DNA Damage; Drug Synergism; Etoposide; Female; Humans; Mice; Papillomavirus Infections; Phosphoinositide-3 Kinase Inhibitors; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2017 |
Case report: term birth after fertility-sparing treatments for stage IB1 small cell neuroendocrine carcinoma of the cervix.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Fertility; Humans; Ifosfamide; Neoplasm Staging; Pregnancy; Term Birth; Uterine Cervical Neoplasms | 2017 |
Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Kaplan-Meier Estimate; Neoplasm Staging; Retrospective Studies; Uterine Cervical Neoplasms | 2017 |
Clinical impact of boost irradiation to pelvic lymph node in uterine cervical cancer treated with definitive chemoradiotherapy.
Topics: Brachytherapy; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Outcome and Process Assessment, Health Care; Pelvis; Radiotherapy Dosage; Republic of Korea; Uterine Cervical Neoplasms | 2018 |
Outcomes and treatments of IB1 cervical cancers with high recurrence risk: A 13 years' experience.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Iridium Radioisotopes; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Recurrence; Retrospective Studies; Risk; Treatment Outcome; Uterine Cervical Neoplasms | 2018 |
Small-cell neuroendocrine carcinoma of the uterine cervix with pancreatic metastasis: a case report and a review of the literature.
Topics: Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Humans; Neoplasm Invasiveness; Palliative Care; Pancreatic Neoplasms; Uterine Cervical Neoplasms; Whole Body Imaging | 2019 |
The RNase PARN Controls the Levels of Specific miRNAs that Contribute to p53 Regulation.
Topics: 3' Untranslated Regions; Antineoplastic Agents; Cell Survival; DEAD-box RNA Helicases; Doxorubicin; Etoposide; Exoribonucleases; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; HeLa Cells; Humans; MicroRNAs; Polyadenylation; Ribonuclease III; Ribonucleases; RNA Nucleotidyltransferases; RNA Stability; Signal Transduction; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2019 |
Star-PAP controls HPV E6 regulation of p53 and sensitizes cells to VP-16.
Topics: Antineoplastic Agents, Phytogenic; Cell Proliferation; DNA-Binding Proteins; Etoposide; Female; Gene Expression; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Nucleotidyltransferases; Oncogene Proteins, Viral; Papillomavirus Infections; Polyadenylation; Polynucleotide Adenylyltransferase; RNA, Messenger; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2014 |
Is neoadjuvant chemotherapy followed by radical surgery more effective than radiation therapy for stage IIB cervical cancer?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms | 2013 |
Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Paclitaxel; Retrospective Studies; Taxoids; Uterine Cervical Neoplasms; Young Adult | 2014 |
The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pelvic Neoplasms; Prognosis; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Remission Induction; Retrospective Studies; Survival Rate; Uterine Cervical Neoplasms | 2015 |
IER3 is a crucial mediator of TAp73β-induced apoptosis in cervical cancer and confers etoposide sensitivity.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Female; HeLa Cells; Humans; Membrane Proteins; Nuclear Proteins; Tumor Protein p73; Tumor Suppressor Proteins; Uterine Cervical Neoplasms | 2015 |
Effects and toxicity of neoadjuvant chemotherapy preoperative followed by adjuvant chemoradiation in small cell neurdendocrine cervical carcinoma.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Doxorubicin; Etoposide; Female; Hepatic Insufficiency; Humans; Hysterectomy; Ifosfamide; Middle Aged; Neoadjuvant Therapy; Neutropenia; Paclitaxel; Renal Insufficiency; Thrombocytopenia; Treatment Outcome; Uterine Cervical Neoplasms; Vincristine | 2015 |
Bcl10 crucially nucleates the pro-apoptotic complexes comprising PDK1, PKCζ and caspase-3 at the nuclear envelope of etoposide-treated human cervical carcinoma C4-I cells.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Phytogenic; Apoptosis; B-Cell CLL-Lymphoma 10 Protein; Caspase 3; Cell Line, Tumor; Cervix Uteri; Etoposide; Female; Humans; Nuclear Envelope; Protein Kinase C; Uterine Cervical Neoplasms | 2015 |
A patient with cancer and nail pigmentation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Black or African American; Cyclophosphamide; Doxorubicin; Etoposide; Febrile Neutropenia; Female; Humans; Lymphoma, B-Cell; Nail Diseases; Nails; Pigmentation Disorders; Prednisone; Uterine Cervical Neoplasms; Vincristine | 2016 |
STAT3/IRF1 Pathway Activation Sensitizes Cervical Cancer Cells to Chemotherapeutic Drugs.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Proliferation; Cisplatin; Etoposide; Female; Humans; Immunoenzyme Techniques; Interferon Regulatory Factor-1; Neoplasm Staging; Precancerous Conditions; Prognosis; STAT3 Transcription Factor; Tumor Cells, Cultured; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2016 |
Nonsurgical Management of Neuroendocrine Cancer of the Cervix: Brief Report.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Female; Humans; Middle Aged; Missouri; Retrospective Studies; Uterine Cervical Neoplasms | 2016 |
Glassy cell carcinoma of the uterine cervix responsive to neoadjuvant intraarterial chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Combined Modality Therapy; Epirubicin; Etoposide; Female; Humans; Hysterectomy; Infusions, Intra-Arterial; Neoadjuvant Therapy; Neoplasm Staging; Treatment Outcome; Uterine Cervical Neoplasms | 2008 |
Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
Large-cell neuroendocrine carcinoma of the uterine cervix complicating pregnancy.
Topics: Abortion, Induced; Adult; Antineoplastic Agents, Phytogenic; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cervix Uteri; Etoposide; Female; Humans; Polyps; Pregnancy; Pregnancy Complications, Neoplastic; Treatment Outcome; Uterine Cervical Neoplasms | 2009 |
Isothiocyanates sensitize the effect of chemotherapeutic drugs via modulation of protein kinase C and telomerase in cervical cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Doxorubicin; Drug Synergism; Etoposide; Female; Gene Expression Regulation, Enzymologic; HeLa Cells; Humans; Isothiocyanates; Protein Kinase C; Telomerase; Uterine Cervical Neoplasms | 2009 |
[Mullerian adenosarcoma of the uterus: A clinicopathologic analysis of 9 cases].
Topics: Adenosarcoma; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Endometrial Neoplasms; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Ifosfamide; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Retrospective Studies; Uterine Cervical Neoplasms; Uterine Neoplasms; Young Adult | 2010 |
Human papillomavirus E1 and E2 mediated DNA replication is not arrested by DNA damage signalling.
Topics: Antigens, Viral, Tumor; Cell Line; DNA Breaks, Double-Stranded; DNA Damage; DNA Replication; DNA-Binding Proteins; DNA, Viral; Etoposide; Female; Genomic Instability; Human papillomavirus 11; Humans; Papillomaviridae; Papillomavirus Infections; Signal Transduction; Uterine Cervical Neoplasms; Viral Proteins; Virus Integration; Virus Replication | 2010 |
Presentation of a patient with pT2bN1M0 small cell carcinoma of the uterine cervix who obtained long-term survival with maintenance chemotherapy, and literature-based discussion.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Neoplasm Staging; Uterine Cervical Neoplasms | 2011 |
Evaluation of oral etoposide in combination with cisplatin for patients with recurrent cervical cancer: long-term follow-up results of a Japanese multicenter study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Japan; Middle Aged; Recurrence; Uterine Cervical Neoplasms | 2011 |
Cisplatinum combined with etoposide. Effective therapy for metastasised squamous-cell carcinoma of the cervix.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis; Uterine Cervical Neoplasms | 2011 |
Uterine cervical malignant granular cell tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cervix Uteri; Cisplatin; Etoposide; Female; Granular Cell Tumor; Humans; Ifosfamide; Incidental Findings; Neoadjuvant Therapy; Treatment Outcome; Uterine Cervical Neoplasms | 2012 |
Small cell neuroendocrine carcinoma of the cervix: analysis of the prognosis and role of radiation therapy for 43 cases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Neuroendocrine; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Time Factors; Uterine Cervical Neoplasms | 2012 |
Role-shifting PKCζ fosters its own proapoptotic destruction by complexing with Bcl10 at the nuclear envelope of human cervical carcinoma cells: a proteomic and biochemical study.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents, Phytogenic; Apoptosis; B-Cell CLL-Lymphoma 10 Protein; Caspase 3; Cell Line, Tumor; Etoposide; Female; Gene Knockdown Techniques; Humans; Immunoprecipitation; Nuclear Envelope; Phosphorylation; Protein Binding; Protein Interaction Mapping; Protein Kinase C; Protein Processing, Post-Translational; Proteome; Proteomics; RNA Interference; Uterine Cervical Neoplasms | 2012 |
The ubiquitin-conjugating enzyme E2-EPF is overexpressed in cervical cancer and associates with tumor growth.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Etoposide; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Nude; Paclitaxel; Promoter Regions, Genetic; Reference Values; RNA, Small Interfering; Topoisomerase I Inhibitors; Topoisomerase Inhibitors; Topotecan; Ubiquitin-Conjugating Enzymes; Uterine Cervical Neoplasms | 2012 |
Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Humans; Middle Aged; Paclitaxel; Radiotherapy Dosage; Survival Rate; Uterine Cervical Neoplasms | 2003 |
[On pre-irradiation of the parametrium in operable cervical carcinoma with moving beam irradiation].
Topics: Carmustine; Etoposide; Female; Humans; Mesentery; Pelvic Floor; Radiotherapy; Uterine Cervical Neoplasms | 1963 |
A young woman with clear cell adenocarcinoma of the uterine cervix.
Topics: Adenocarcinoma, Clear Cell; Adolescent; Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinogens; Diethylstilbestrol; Etoposide; Female; Humans; Hysterectomy; Japan; Lymph Node Excision; Mitomycin; Neoadjuvant Therapy; Netherlands; Prognosis; Uterine Cervical Neoplasms | 2003 |
[Metastatic cancer in transposed ovaries after radical Wertheim-Meigs hysterectomy for a stage I B and II A cervical cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Mitomycin; Neoplasm Staging; Ovarian Neoplasms; Ovary; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Radiotherapy, Adjuvant; Statistics as Topic; Treatment Outcome; Uterine Cervical Neoplasms; Women's Health | 2004 |
Response of early stage bulky cervical squamous carcinoma to preoperative adjuvant chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Preoperative Care; Uterine Cervical Neoplasms; Vincristine | 2004 |
Phosphorylated histone H2AX in spheroids, tumors, and tissues of mice exposed to etoposide and 3-amino-1,2,4-benzotriazine-1,3-dioxide.
Topics: Animals; Antineoplastic Agents; Cell Survival; DNA Damage; Etoposide; Female; Flow Cytometry; Histones; Humans; Hypoxia; Kidney; Mice; Mice, Inbred NOD; Mice, SCID; Phosphorylation; Spheroids, Cellular; Spleen; Tirapazamine; Transplantation, Heterologous; Triazines; Tumor Stem Cell Assay; Uterine Cervical Neoplasms | 2004 |
High-grade neuroendocrine carcinoma of the cervix. A case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Combined Modality Therapy; Etoposide; Female; Gynecologic Surgical Procedures; Humans; Neoplasm Staging; Radiotherapy, Adjuvant; Treatment Outcome; Uterine Cervical Neoplasms | 2005 |
Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 6; Caspases; Cell Cycle; Cell Line, Tumor; Deoxyadenosines; DNA Fragmentation; Etoposide; Female; Humans; Isoenzymes; Neoplasms, Glandular and Epithelial; Polynucleotide Adenylyltransferase; Time Factors; Uterine Cervical Neoplasms | 2005 |
Optimal combination chemotherapy and chemoradiotherapy with etoposide for advanced cervical squamous cancer cells in vitro.
Topics: Antigens, CD20; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Squamous Cell; CD40 Antigens; Cell Survival; Clone Cells; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Resistance, Neoplasm; Etoposide; Female; Flow Cytometry; Fluorouracil; Humans; Integrin alpha1; Integrin alpha6; Irinotecan; Mitomycin; Uterine Cervical Neoplasms; X-Rays | 2006 |
hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Catalytic Domain; Cell Line, Tumor; Cell Survival; Cisplatin; Colonic Neoplasms; DNA-Binding Proteins; Etoposide; fas Receptor; Female; Humans; Mitochondria; Mitomycin; Reactive Oxygen Species; Telomerase; Uterine Cervical Neoplasms | 2006 |
[Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
Topics: Adult; Antineoplastic Agents; Bleomycin; Carboplatin; Carcinoma, Squamous Cell; Cell Survival; Cells, Cultured; Cisplatin; Cyclophosphamide; Drug Screening Assays, Antitumor; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Paclitaxel; Uterine Cervical Neoplasms | 2007 |
Caspase-independent autophagic cytotoxicity in etoposide-treated CaSki cervical carcinoma cells.
Topics: Adenine; Amino Acid Chloromethyl Ketones; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Caspase Inhibitors; Caspases; Cell Line, Tumor; Etoposide; Female; Humans; Macrolides; Membrane Proteins; Uterine Cervical Neoplasms | 2007 |
Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Etoposide; Female; Humans; Middle Aged; Podophyllotoxin; Uterine Cervical Neoplasms | 1984 |
DNA strand breakage and DNA structure influence staining with propidium iodide using the alkaline comet assay.
Topics: Alkalies; Animals; Bisbenzimidazole; Cell Line; Cricetinae; Cricetulus; DNA Damage; DNA, Single-Stranded; Electrophoresis, Agar Gel; Etoposide; Female; Fibroblasts; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Indoles; Lung; Male; Methylnitronitrosoguanidine; Microscopy, Fluorescence; Nucleic Acid Conformation; Nucleic Acid Denaturation; Propidium; Staining and Labeling; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1994 |
[Experimental and clinical study on chemotherapy for cervical adenocarcinoma].
Topics: Aclarubicin; Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mitomycin; Neoplasm Transplantation; Uterine Cervical Neoplasms | 1995 |
[A case report: complete remission of stage IV uterine cervix carcinoma by immuno-chemotherapy with intraarterial infusion using implantable reservoir system].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Hysterectomy; Immunotherapy; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Lymph Node Excision; Picibanil; Remission Induction; Tegafur; Uracil; Uterine Cervical Neoplasms | 1995 |
[Simultaneous radiochemotherapy in locally advanced cancers of the cervix: a preliminary study].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Radiotherapy Dosage; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms | 1995 |
Effects of single and combined application of anti-cancer drugs on cervical adenocarcinoma. I. Antitumor activity in vitro.
Topics: Adenocarcinoma; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Combined Modality Therapy; Etoposide; Female; Humans; In Vitro Techniques; Interferon-gamma; Mice; Mice, Nude; Middle Aged; Mitomycin; Neoplasms, Experimental; Recombinant Proteins; Uterine Cervical Neoplasms | 1995 |
Potentiation of tumour necrosis factor-mediated cell killing by VP16 on human ovarian cancer cell lines. In vitro results and clinical implications.
Topics: Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Humans; Ovarian Neoplasms; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Stem Cell Assay; Uterine Cervical Neoplasms | 1993 |
High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Radiation; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Radiation Injuries; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 1996 |
Absence of correlation between chemo- and radioresistance in a range of human tumour cell lines.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Carcinoma; Carcinoma, Squamous Cell; Cell Division; Cisplatin; Clone Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; HeLa Cells; Humans; Laryngeal Neoplasms; Lung Neoplasms; Neoplasms; Ovarian Neoplasms; Radiation Tolerance; Selection, Genetic; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Vincristine | 1996 |
[Two cases of adenosquamous cell carcinoma of advanced cervical cancer treated by carboplatin-based chemotherapy with peripheral blood stem cell autotransplant].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Uterine Cervical Neoplasms | 1997 |
Clonal analysis of cancer cells that survived anticancer drug treatment.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Squamous Cell; Cell Survival; Doxorubicin; Enzyme Inhibitors; Etoposide; Female; Humans; Irinotecan; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1997 |
[CDDP-resistant early recurrent uterine cervical cancer successfully treated with low-dose oral etoposide: a case report].
Topics: Administration, Oral; Adult; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Remission Induction; Uterine Cervical Neoplasms | 1998 |
Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Middle Aged; Mitomycin; Neoplasm Staging; Uterine Cervical Neoplasms | 1998 |
Rapid progression of squamous cell carcinoma of the cervix after hyperbaric oxygenation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Fatal Outcome; Female; Humans; Hyperbaric Oxygenation; Lymph Node Excision; Lymphatic Diseases; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 1999 |
Small cell carcinoma of the cervix complicated by pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Diagnosis, Differential; Etoposide; Female; Humans; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Uterine Cervical Neoplasms | 1999 |
Metastatic carcinoma in a transposed ovary after radical hysterectomy for a stage 1B cervical adenosquamous cell carcinoma. Case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Mitomycin; Ovarian Neoplasms; Ovariectomy; Ovary; Uterine Cervical Neoplasms | 2000 |
Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Cricetinae; Cricetulus; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Female; Fibroblasts; Glioma; Humans; Isoenzymes; Mice; Mice, Inbred NOD; Mice, SCID; Spheroids, Cellular; Subcellular Fractions; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2000 |
Anti-neoplastic activity of topotecan versus cisplatin, etoposide and paclitaxel in four squamous cell cancer cell lines of the female genital tract using an ATP-Tumor Chemosensitivity Assay.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Etoposide; Female; Humans; Luminescent Measurements; Paclitaxel; Topotecan; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Vulvar Neoplasms | 2000 |
Primary high-grade mucosa-associated lymphoid tissue-type lymphoma of the cervix presenting as a common endocervical polyp.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Epirubicin; Etoposide; Female; Humans; Hysterectomy; Immunohistochemistry; In Situ Hybridization; Lymphoma, B-Cell, Marginal Zone; Methotrexate; Middle Aged; Neoplasm Proteins; Polyps; Prednisone; Uterine Cervical Neoplasms; Vincristine | 2001 |
Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing P53.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Ascorbic Acid; bcl-2-Associated X Protein; Cell Cycle; Cisplatin; Down-Regulation; Drug Stability; Drug Synergism; Etoposide; Female; HeLa Cells; Humans; Oncogene Proteins, Viral; Papillomaviridae; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Telomerase; Transcription, Genetic; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 2001 |
Locally advanced cervix cancer: chemotherapy prior to definitive surgery or radiotherapy. A single institutional experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Etoposide; Female; Humans; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Retrospective Studies; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 2001 |
Chemotherapy as initial treatment for cervical carcinoma: clinical and tumor marker response.
Topics: Adenocarcinoma; Antigens, Neoplasm; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Middle Aged; Serpins; Trypsin Inhibitor, Kazal Pancreatic; Uterine Cervical Neoplasms | 1992 |
Cardiac tamponade resulting from recurrent small-cell carcinoma of the uterine cervix temporarily responding to CE/CAV chemotherapy: report of a case.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cardiac Tamponade; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms; Vincristine | 1992 |
[Characterization of two novel cell lines established from a single human uterine cervical adenocarcinoma, and their chemosensitivities and hormonal effects on their proliferation].
Topics: Adenocarcinoma; Animals; Carbazilquinone; Cell Division; Drug Screening Assays, Antitumor; Estradiol; Etoposide; Female; Humans; Methotrexate; Mice; Mitomycin; Neoplasm Transplantation; Progesterone; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1992 |
Etoposide (VP-16), ifosfamide/mesna, and cisplatin chemotherapy for advanced and recurrent carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Etoposide; Female; Hematologic Diseases; Humans; Ifosfamide; Mesna; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1991 |
[In vitro combined effects of pirarubicin (THP) and various antitumor drugs on human tumor cell lines].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Female; Humans; Leukemia, Myeloid; Methotrexate; Mitomycin; Mitomycins; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1990 |
Squamous cell carcinoma antigen and carcinoembryonic antigen levels as prognostic factors for the response of cervical carcinoma to chemotherapy.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoembryonic Antigen; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Neoplasm Metastasis; Organoplatinum Compounds; Prognosis; Recurrence; Serpins; Uterine Cervical Neoplasms | 1990 |
Chemotherapy-radiation interactions in human cervix carcinoma xenografts.
Topics: Animals; Bleomycin; Brachytherapy; Cell Line; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Mice; Mice, Nude; Neoplasm Transplantation; Radiotherapy Dosage; Transplantation, Heterologous; Uterine Cervical Neoplasms | 1988 |
In vitro chemosensitivity of four new carcinoma of the cervix cell lines: relationship to radiosensitivity.
Topics: Antineoplastic Agents; Bleomycin; Cell Line; Cisplatin; Drug Tolerance; Etoposide; Female; Humans; Methotrexate; Radiation Tolerance; Tumor Cells, Cultured; Tumor Stem Cell Assay; Uterine Cervical Neoplasms | 1989 |
Cytotoxicity mediated by tumor necrosis factor in variant subclones of the ME-180 cervical carcinoma line: modulation by specific inhibitors of DNA topoisomerase II.
Topics: Cell Communication; Cell Survival; DNA Topoisomerases, Type II; Drug Synergism; Etoposide; Female; Kinetics; Lymphotoxin-alpha; Mitomycin; Mitomycins; Teniposide; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 1989 |
[The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer].
Topics: Adenocarcinoma; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoembryonic Antigen; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Neoplasm Recurrence, Local; Organoplatinum Compounds; Prognosis; Serpins; Uterine Cervical Neoplasms | 1989 |
[A case of recurrent uterine cervical cancer successfully treated with etoposide].
Topics: Administration, Oral; Aged; Drug Administration Schedule; Etoposide; Female; Humans; Neoplasm Recurrence, Local; Prognosis; Uterine Cervical Neoplasms | 1989 |
[Sensitivity to etoposide in cultured cells from cervical squamous cell carcinoma].
Topics: Carcinoma, Squamous Cell; Cell Division; Cells, Cultured; Drug Resistance; Etoposide; Female; Humans; Kinetics; Uterine Cervical Neoplasms | 1986 |
Predictive testing of vulvar and cervical cancers to chemotherapy by the subrenal capsule assay.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Kidney; Methotrexate; Mice; Middle Aged; Neoplasm Transplantation; Tumor Stem Cell Assay; Uterine Cervical Neoplasms; Vulvar Neoplasms | 1985 |